Navigation Links
Bruin Biometrics, LLC Achieves Significant Milestone with Receipt of ISO 13485 Certification
Date:12/9/2013

LOS ANGELES, Dec. 9, 2013 /PRNewswire/ -- Bruin Biometrics, LLC ("BBI") an innovative medical device manufacturer, announced today that it has received ISO 13485:2003 and EN ISO 13485:2012 certification, including CMDCAS certification, for its Quality Management System with its notified body SGS. Receipt of ISO 13485 certification demonstrates BBI's commitment to quality in the design, development, manufacture, and distribution of non-invasive diagnostic medical devices. The ISO standard also assures BBI partners and customers that its products and processes conform to international quality standards.

(Logo: http://photos.prnewswire.com/prnh/20131018/LA00429LOGO

"Achieving ISO 13485 certification is a substantial milestone for BBI. It demonstrates BBI's continued commitment to the highest level of quality management and service, and to ensure distribution of safe and effective medical devices," said Armin Beck, Vice President of QA/RA/CA & commercial operation for BBI.

BBI is privately-held and based in Los Angeles, California. For additional information, please visit www.bruinbiometrics.com.

 

 


'/>"/>
SOURCE Bruin Biometrics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Bruin Biometrics, LLC Awarded CE Mark for the SEM Scanner, an Innovative Diagnostic Tool to Detect Pressure Induced Tissue Damage
2. UCI achieves rare trifecta: 3 scientists receive New Innovator Awards
3. DO-HEALTH a multi-center clinical trial on healthy ageing achieves first milestone
4. Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk
5. Targeted treatment can significantly reduce relapse in children with AML leukemia
6. Children are significantly more likely to develop PTSD if the mother is already afflicted
7. Dartmouth-led study shows diet alone can be significant source of arsenic
8. Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients
9. Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels
10. Global cooling as significant as global warming
11. Synthetic biology research community grows significantly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 /PRNewswire/ ... of genomic services and solutions with cutting edge next-generation ... has completed a USD $75 Million [515 Million RMB] ... CMB International Capital Management ( Shenzhen ) ... Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment Center ...
Breaking Biology Technology: